Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-08-27 Sale |
2021-08-31 4:48 pm |
Cullinan Oncology Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
50,489 | $29.24 | $1,476,135 | 8,021,277 (Indirect Direct) |
View |
2021-08-27 Sale |
2021-08-31 4:47 pm |
Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. BioImpact Capital LLC 10% Owner |
44,358 | $29.24 | $1,296,884 | 7,761,125 (Direct) |
View |
2021-08-09 Sale(A) |
2021-08-26 7:20 pm |
Cullinan Oncology Inc. | CGEM | Zawel Leigh See Remarks |
28,118 | $26.77 | $752,850 | 121,642 (Direct) |
View |
2021-08-18 Sale(A) |
2021-08-26 7:15 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $27.66 | $110,648 | 248,889 (Direct) |
View |
2021-08-23 Sale(A) |
2021-08-26 7:14 pm |
Cullinan Oncology Inc. | CGEM | Zawel Leigh See Remarks |
28,118 | $29 | $815,422 | 93,524 (Direct) |
View |
2021-08-10 Sale |
2021-08-26 7:11 pm |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $27 | $297,000 | 592,548 (Indirect Direct) |
View |
2021-08-23 Sale |
2021-08-25 7:42 pm |
Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
105,894 | $29.29 | $3,101,344 | 7,805,483 (Direct) |
View |
2021-08-23 Sale |
2021-08-25 7:41 pm |
Cullinan Oncology Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
120,592 | $29.29 | $3,531,820 | 8,071,766 (Indirect Direct) |
View |
2021-08-23 Sale |
2021-08-24 4:06 pm |
Cullinan Oncology Inc. | CGEM | Zawel Leigh See Remarks |
28,118 | $29 | $815,422 | 93,524 (Direct) |
View |
2021-08-18 Sale |
2021-08-24 4:06 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $27.66 | $110,648 | 248,889 (Direct) |
View |
2021-08-11 Sale |
2021-08-12 4:55 pm |
Cullinan Oncology Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
2,510 | $29.05 | $72,916 | 7,911,377 (Direct) |
View |
2021-08-11 Sale |
2021-08-12 4:54 pm |
Cullinan Oncology Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
2,857 | $29.05 | $82,996 | 8,192,298 (Indirect Direct) |
View |
2021-08-09 Sale |
2021-08-11 4:15 pm |
Cullinan Oncology Inc. | CGEM | Zawel Leigh See Remarks |
28,118 | $26.77 | $752,850 | 121,642 (Direct) |
View |
2021-01-12 Purchase |
2021-01-14 5:54 pm |
Cullinan Management Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
300,000 | $21 | $6,300,000 | 7,913,887 (Direct) |
View |
2021-01-12 Purchase |
2021-01-14 5:51 pm |
Cullinan Management Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
300,000 | $21 | $6,300,000 | 16,441,248 (Indirect Direct) |
View |
2021-01-12 Purchase |
2021-01-14 5:30 pm |
Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner |
200,000 | $21 | $4,200,000 | 217,269 (Indirect Direct) |
View |
2021-01-12 Purchase |
2021-01-14 5:30 pm |
Cullinan Management Inc. | CGEM | Hughes Owen President and CEO |
2,500 | $21 | $52,500 | 506,226 (Direct) |
View |
2021-01-12 Purchase |
2021-01-14 5:30 pm |
Cullinan Management Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer |
2,250 | $21 | $47,250 | 2,250 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-08-18 Exercise(A) |
2021-08-26 7:15 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $4.3 | 248,889 (Direct) |
View |
2021-08-18 Exercise(A) |
2021-08-26 7:15 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $0 | 248,889 (Direct) |
View |
2021-08-10 Exercise |
2021-08-26 7:11 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $4.3 | 592,548 (Direct) |
View |
2021-08-10 Exercise |
2021-08-26 7:11 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $0 | 592,548 (Direct) |
View |
2021-08-18 Exercise |
2021-08-24 4:06 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $4.3 | 248,889 (Direct) |
View |
2021-08-18 Exercise |
2021-08-24 4:06 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $0 | 248,889 (Direct) |
View |
2021-01-12 Conversion |
2021-01-14 5:54 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
7,613,887 | $0 | 7,913,887 (Direct) |
View |
2021-01-12 Conversion |
2021-01-14 5:51 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
7,613,887 | $0 | 16,441,248 (Indirect) |
View |
2021-01-07 Other |
2021-01-14 5:51 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
8,246,093 | $0 | 16,441,248 (Indirect) |
View |
Ownership(A) |
2021-01-14 5:49 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner |
0 | $0 | 7,613,887 (Direct) |
View |
2021-01-12 Conversion |
2021-01-14 5:30 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC F2 GC LLC Director 10% Owner |
46,770,331 | $0 | 217,269 (Indirect) |
View |
2021-01-07 Option Award |
2021-01-11 5:37 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Baeuerle Patrick See Remarks |
286,665 | $0 | 286,665 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 5:36 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Zawel Leigh See Remarks |
56,666 | $0 | 56,666 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 5:35 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Michaelson Jennifer See Remarks |
79,999 | $0 | 79,999 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 5:35 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Hughes Owen President and CEO |
433,332 | $0 | 433,332 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 5:33 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer |
146,665 | $0 | 146,665 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 5:32 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Wigginton Jon Marc Chief Medical Officer |
116,666 | $0 | 116,666 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 5:31 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Keane Raymond T Chief Legal Officer |
249,998 | $0 | 249,998 (Direct) |
View |
Ownership |
2021-01-07 8:55 pm |
N/A 2030-10-28 |
Cullinan Management Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer |
0 | $0 | 252,891 (Direct) |
View |
Ownership |
2021-01-07 8:45 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Michaelson Jennifer See Remarks |
0 | $0 | 252,889 (Direct) |
View |
Ownership |
2021-01-07 8:42 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Rosenberg Anthony Director |
0 | $0 | 252,886 (Direct) |
View |
Ownership |
2021-01-07 8:40 pm |
N/A 2030-10-28 |
Cullinan Management Inc. | CGEM | Webster Stephen W Director |
0 | $0 | 25,289 (Direct) |
View |
Ownership |
2021-01-07 8:40 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Ebeling Thomas Director |
0 | $0 | 151,728 (Direct) |
View |
Ownership |
2021-01-07 8:40 pm |
N/A 2030-10-28 |
Cullinan Management Inc. | CGEM | Wigginton Jon Marc Chief Medical Officer |
0 | $0 | 632,228 (Direct) |
View |
Ownership |
2021-01-07 8:40 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Zawel Leigh See Remarks |
0 | $0 | 341,391 (Direct) |
View |
Ownership |
2021-01-07 8:37 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | UBS Oncology Impact Fund L.P. 10% Owner |
0 | $0 | 7,613,887 (Direct) |
View |
Ownership |
2021-01-07 8:37 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | GADICKE ANSBERT Director 10% Owner |
0 | $0 | 8,246,093 (Direct) |
View |
Ownership |
2021-01-07 8:34 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Baeuerle Patrick See Remarks |
0 | $0 | 1,011,541 (Indirect) |
View |
Ownership |
2021-01-07 8:34 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Keane Raymond T Chief Legal Officer |
0 | $0 | 1,624 (Direct) |
View |
Ownership |
2021-01-07 8:32 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Jovan-Embiricos Morana Globeways Holdings Ltd F2 Vision SCS F2 Bioscience I 2017 Ltd F2 MG Ltd F2 - TPO Investments LLC F2 Bio TD LLC F2 MC LLC Director 10% Owner |
0 | $0 | 6,079,713 (Direct) |
View |
Ownership |
2021-01-07 8:31 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Hughes Owen President and CEO |
0 | $0 | 1,365,578 (Direct) |
View |
Ownership |
2021-01-07 8:29 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Savill Corrine Acting Chief Business Officer |
0 | $0 | 379,321 (Direct) |
View |